Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9010 | 1128 | 30.1 | 45% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2876 | 2345 | THYMOSIN BETA 4//PROTHYMOSIN ALPHA//THYMOSIN ALPHA 1 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | THYMULIN | Author keyword | 53 | 57% | 6% | 64 |
2 | THYMOPENTIN | Author keyword | 20 | 43% | 3% | 36 |
3 | SPLENOPENTIN | Author keyword | 18 | 89% | 1% | 8 |
4 | THYMIC HORMONES | Author keyword | 12 | 50% | 2% | 18 |
5 | THYMOPOIETIN | Author keyword | 9 | 48% | 1% | 14 |
6 | RAD FTS | Author keyword | 8 | 100% | 0% | 5 |
7 | THYMULIN GENE THERAPY | Author keyword | 8 | 100% | 0% | 5 |
8 | THYMOPENTIN ANALOGS | Author keyword | 6 | 80% | 0% | 4 |
9 | THYMOSTIMULIN | Author keyword | 6 | 38% | 1% | 12 |
10 | MB35 | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THYMULIN | 53 | 57% | 6% | 64 | Search THYMULIN | Search THYMULIN |
2 | THYMOPENTIN | 20 | 43% | 3% | 36 | Search THYMOPENTIN | Search THYMOPENTIN |
3 | SPLENOPENTIN | 18 | 89% | 1% | 8 | Search SPLENOPENTIN | Search SPLENOPENTIN |
4 | THYMIC HORMONES | 12 | 50% | 2% | 18 | Search THYMIC+HORMONES | Search THYMIC+HORMONES |
5 | THYMOPOIETIN | 9 | 48% | 1% | 14 | Search THYMOPOIETIN | Search THYMOPOIETIN |
6 | RAD FTS | 8 | 100% | 0% | 5 | Search RAD+FTS | Search RAD+FTS |
7 | THYMULIN GENE THERAPY | 8 | 100% | 0% | 5 | Search THYMULIN+GENE+THERAPY | Search THYMULIN+GENE+THERAPY |
8 | THYMOPENTIN ANALOGS | 6 | 80% | 0% | 4 | Search THYMOPENTIN+ANALOGS | Search THYMOPENTIN+ANALOGS |
9 | THYMOSTIMULIN | 6 | 38% | 1% | 12 | Search THYMOSTIMULIN | Search THYMOSTIMULIN |
10 | MB35 | 6 | 100% | 0% | 4 | Search MB35 | Search MB35 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SERUM THYMIC FACTOR | 29 | 66% | 2% | 27 |
2 | HOMEOSTATIC THYMUS HORMONE | 27 | 92% | 1% | 11 |
3 | THYMOSTIMULIN | 21 | 90% | 1% | 9 |
4 | THYMOPOIETIN PENTAPEPTIDE | 20 | 100% | 1% | 9 |
5 | THYMOSIN PEPTIDES | 19 | 76% | 1% | 13 |
6 | CONGENITALLY ATHYMIC MICE | 18 | 89% | 1% | 8 |
7 | THYMOPOIETIN | 17 | 42% | 3% | 32 |
8 | THYMOSIN | 13 | 41% | 2% | 24 |
9 | IMMUNOREGULATORY PEPTIDE | 12 | 86% | 1% | 6 |
10 | FACTOR FTS | 10 | 73% | 1% | 8 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SURVEY OF IMMUNOLOGIC RESEARCH | 2 | 12% | 2% | 20 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Thymopentin and splenopentin as immunomodulators - Current status | 1998 | 25 | 88 | 67% |
Thymic peptides for treatment of cancer patients | 2011 | 4 | 34 | 53% |
Thymulin and the neuroendocrine system | 2004 | 13 | 46 | 83% |
Thymus hormones as prospective anti-inflammatory agents | 2010 | 5 | 79 | 44% |
Neuroendocrine control of thymus physiology | 2000 | 155 | 335 | 20% |
Potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models | 2008 | 1 | 29 | 83% |
Plasticity of neuroendocrine-thymus interactions during ontogeny and ageing: Role of zinc and arginine | 2006 | 19 | 120 | 23% |
Immunomodulatory role of thymulin in lung diseases | 2010 | 1 | 84 | 56% |
Thymus therapy for cancer? A criteria-based, systematic review | 1997 | 8 | 19 | 63% |
Immunopotentiating and immunotherapeutic effects of thymic hormones and factors with special emphasis on thymic humoral factor THF-gamma 2 | 1999 | 13 | 145 | 40% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INIBIOLP | 2 | 13% | 1.5% | 17 |
2 | MED CHAIR IMMUNOL | 2 | 67% | 0.2% | 2 |
3 | CYTOL HISTOL EMBRYOL B | 2 | 50% | 0.3% | 3 |
4 | INIBIOLP HISTOL B | 1 | 25% | 0.4% | 5 |
5 | MICROWAVE SAFETY | 1 | 14% | 0.5% | 6 |
6 | URA 1461 | 1 | 15% | 0.4% | 5 |
7 | HISTOL EMBRYOL B | 1 | 33% | 0.2% | 2 |
8 | CAECHIS | 1 | 50% | 0.1% | 1 |
9 | DIPARTIMENTO MED PROCREAZIONE ETA EVOLUT | 1 | 50% | 0.1% | 1 |
10 | IMMUNOL EXPTL THER Y | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000205502 | THYMOSIN BETA 4//PROTHYMOSIN ALPHA//THYMOSIN ALPHA 1 |
2 | 0.0000103724 | THYMUS//THYMIC NURSE CELLS//THYMIC MICROENVIRONMENT |
3 | 0.0000091795 | ST PETERSBURG BIOREGULAT GERONTOL//EPITHALON//NORTHWESTERN |
4 | 0.0000075333 | CRYPTOCRINE SIGNALING//NEUROENDOCRINE SELF ANTIGENS//PATHOL CHUB23 |
5 | 0.0000069116 | IMMUNE ENDOCRINE//HISTOTYPIC CULTURES//MERVIN BOVAIRD STUDIES MOL BIOL BIOTECHNOL |
6 | 0.0000063957 | ALPHA NAPHTHYL AS ACETATE ESTERASE//MORPHINE NALOXONE//NONSPECIFIC ORGANISMS RESISTANCE |
7 | 0.0000061643 | MEDTAYSIDE CHILD HLTH//CHEMIOXYEXCITATION//GLUTATHIONE DISEQUILIBRIUM |
8 | 0.0000060512 | EDWARD R MADIGAN 207//BIOACTIVE PROLACTIN//THYMUS |
9 | 0.0000056767 | EVANS IMMUNOL//HLTH SCI 304//LUPRON DEPOT |
10 | 0.0000053779 | TOSO//FC MU R//RAT IMMUNOCYTOMA |